Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected Farhat Nasim6 Jan 2020 7:45 AM GMTNew Delhi: In a major setback to Ranbaxy Laboratories Limited (now Sun Pharmaceutical Industries Ltd.), the Department of Pharmaceuticals (DoP) has...
Minister informs Parliament about steps taken to promote affordable generic drugs Medical Dialogues Bureau26 Nov 2019 11:00 AM GMTNew Delhi: The Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently informed the Parliament about the steps taken by the...
DOP junks Cipla plea to refix MRP of Tafmune–EM Farhat Nasim2 Sep 2019 11:04 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules Farhat Nasim28 July 2019 6:00 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Geltec Private Limited...
Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA Meghna A Singhania23 Jun 2019 11:27 AM GMTNew Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department...
Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea Farhat Nasim16 Jun 2019 6:14 AM GMTNew Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...
DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5 Meghna A Singhania6 May 2019 5:53 AM GMTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Launching product without Approval: DOP rejects Biocon Plea against NPPA action Meghna A Singhania24 Feb 2019 5:55 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
Price Ceiling, Compulsory licensing of patented medicines Necessary: Govt panel Medical Dialogues Bureau28 Jan 2019 7:20 AM GMTWorried about "high prices" and "unaffordability" of patented medicines in India, the Department of Pharmaceuticals (DOP) formed this...
DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations Medical Dialogues Bureau23 Sep 2018 7:09 AM GMT Department of Pharmaceutical rejected the review petition of Lupin " Lupin has not implemented the price notification"New Delhi: Through a recent...
HC Rescues Lupin on Price cap on powdered form of asthma drug Ruby Khatun Khatun22 April 2018 6:28 AM GMTNew Delhi: The Delhi High Court directed the Centre not to take any coercive measure against Indian pharma major Lupin Ltd which has challenged a...
Now non-essential drugs fall under price control Ruby Khatun Khatun23 Oct 2017 12:15 PM GMTNew Delhi: The government's push for a change in the method of price calculation methodology for new drugs can lead to non-essential drugs coming...
